Invest with Purpose

Essential News

Bayer Buys Properties for its Long-Term Project in Costa Rica

Bayer Buys Properties for its Long-Term Project in Costa Rica

  • Bayer sees Costa Rica as having strong potential for its business plans.
  • Costa Rica offers many options for Bayer, such as its strategic location, pro-development, and private investment policies.

    Costa Rica, March 3, 2021. Bayer, a global company with headquarters in Germany and focused on bio-health sciences and nutrition, has decided to buy property adjacent to the Coyol Industrial Park in Alajuela as part of its long-term regional business expansion plans.

    With more than forty years in Costa Rica, the multinational has administrative offices in Escazú and a medical device plant in Heredia and has expanded its regional operations through its Shared Services Center, located in Alajuela, which has grown from 25 employees in 2017 to more than 600 in 2020. The need for health resources, including Bayer’s pharmaceutical products, is growing continuously with a growing and aging global population and an expanding panorama of chronic diseases.

    For Bayer, Costa Rica is still a key site where it promotes research and development of agricultural solutions on two properties: one in Limón for fruit trees, and another in Guanacaste for cottonseed production.

    “As a company, we appreciate enormously the availability of technically skilled talent, the solid cooperation between the business community and public sector, and the demonstrated leadership in environmental sustainability,” affirmed Christian A. Meyer, company president and CEO of Bayer’s pharmaceutical division for the region that includes Costa Rica.

    About Bayer

     Bayer is a multinational company with core competencies in food and health biosciences. With its products and services, the company wants to be useful to humanity, helping to find solutions to the fundamental challenges posed by the steadily aging and growing world population. At the same time, the Group seeks to increase its returns and create value through innovation and growth. Bayer adheres to the principle of sustainability, and its brands are synonymous with trust, reliability, and quality the world over. In the fiscal year 2019, the Group had some 104,000 employees, invoiced 43.5 billion euros, invested 2.9 billion euros, and allocated 5.3 billion euros to research and development. For more information, visit its website,